Leading Smart Retinal Implants Market Companies: A Detailed Profile

By /

Smart Retinal Implants Market Companies

Smart Retinal Implants Market Companies
  • Second Sight Medical Products, Inc.
  • Retina Implant AG
  • Pixium Vision SA
  • Bionic Vision Technologies
  • Nano Retina, Inc.
  • Intelligent Implants GmbH
  • iBionics
  • Optobionics Corporation
  • VisionCare Ophthalmic Technologies
  • Ocumetics Technology Corporation
  • Nidek Co., Ltd.
  • Boston Scientific Corporation
  • Medtronic plc
  • Alcon (Novartis)
  • Johnson & Johnson Vision Care, Inc.
  • Zeiss Group
  • Ophthorobotics AG
  • Gensight Biologics
  • LambdaVision, Inc.
  • Neurotech Pharmaceuticals, Inc.

Download Sample Report

Key Players in the Smart Retinal Implants Market

1. Second Sight Medical Products, Inc.

  • Company Name and Headquarters: Second Sight Medical Products, Inc. (Sylmar, California, USA)

  • Product Offerings related to Smart Retinal Implants:

    • Argus II Retinal Prosthesis System: This was a pioneering device designed to restore some visual function to patients blind due to outer retinal degenerations like retinitis pigmentosa. It works by converting video images from a miniature camera worn on glasses into electrical pulses transmitted wirelessly to an array of electrodes implanted on the retina.

    • Orion Visual Cortical Prosthesis System: This system aims to restore some useful vision by bypassing the damaged optic nerve and directly stimulating the visual cortex of the brain.

  • Market Share and Estimated Revenue from Smart Retinal Implants Segment: Second Sight was a significant early player. While specific revenue for retinal implants is not disclosed, the Argus II was a leading product in its niche. However, the company faced significant financial challenges and has undergone restructuring and a merger with Pixium Vision (see below).

  • Recent Developments, Partnerships, or Innovations: The company ceased operations for a period but has seen a resurgence through its merger with Pixium Vision, forming Novavision. The focus now is on combining their technologies and advancing the Orion system.

  • Competitive Positioning and Strategic Focus: Historically, Second Sight was a first-mover in approved retinal prostheses. Its strategic focus was on commercializing its Argus II and developing the Orion system for a broader range of blind patients. Now, as Novavision, the focus is on leveraging combined expertise.

  • Key Customers or Industries Served: Patients suffering from severe to profound vision loss due primarily to retinitis pigmentosa (for Argus II) and other causes of blindness (for Orion). Ophthalmologists and neurosurgeons are key partners in implementation.

2. Retina Implant AG

  • Company Name and Headquarters: Retina Implant AG (Reutlingen, Germany)

  • Product Offerings related to Smart Retinal Implants:

    • Alpha AMS System (formerly Alpha IMS): This subretinal implant is designed for patients with retinitis pigmentosa. Unlike epiretinal implants, it’s placed directly under the retina, aiming to replicate the natural visual processing more closely. It includes a microphotodiode array that detects light and stimulates the retinal cells directly.

  • Market Share and Estimated Revenue from Smart Retinal Implants Segment: Retina Implant AG was another early pioneer, particularly with its subretinal approach. Its market presence was more niche compared to Second Sight, and specific revenue figures are not public.

  • Recent Developments, Partnerships, or Innovations: The Alpha AMS is their refined product. They have focused on clinical trials and improving the long-term efficacy and safety of their device.

  • Competitive Positioning and Strategic Focus: Retina Implant AG’s strategic focus has been on the subretinal approach, which offers distinct advantages and challenges compared to epiretinal or cortical implants. They aim for a more physiological restoration of vision.

  • Key Customers or Industries Served: Patients with advanced retinitis pigmentosa, primarily in Europe.

3. Pixium Vision SA

  • Company Name and Headquarters: Pixium Vision SA (Paris, France)

  • Product Offerings related to Smart Retinal Implants:

    • PRIMA System (Subretinal implant): A subretinal photovoltaic implant designed for patients with dry Age-related Macular Degeneration (AMD). It’s smaller than previous implants and aims to replace degenerated photoreceptors.

  • Market Share and Estimated Revenue from Smart Retinal Implants Segment: Pixium Vision is a significant player, particularly with its focus on dry AMD, a much larger patient population than retinitis pigmentosa. Specific revenue figures are not publicly disaggregated.

  • Recent Developments, Partnerships, or Innovations: Pixium Vision merged with Second Sight Medical Products to form Novavision, aiming to create a leading player in visual prosthetics. Their PRIMA system has shown promising clinical trial results for dry AMD.

  • Competitive Positioning and Strategic Focus: Pixium Vision’s strategic focus is on addressing dry AMD, a major unmet medical need, using its innovative subretinal PRIMA system. The merger with Second Sight enhances their technology portfolio and market reach.

  • Key Customers or Industries Served: Patients suffering from advanced dry Age-related Macular Degeneration.

4. Bionic Vision Technologies (BVT)

  • Company Name and Headquarters: Bionic Vision Technologies (Melbourne, Australia)

  • Product Offerings related to Smart Retinal Implants:

    • High Acuity Bionic Eye (HAVE) System: BVT has developed both supra-choroidal (placed over the choroid, near the retina) and subretinal implants. Their technology aims for higher resolution vision than earlier implants.

  • Market Share and Estimated Revenue from Smart Retinal Implants Segment: BVT is still largely in the research and development phase, with devices undergoing clinical trials. Therefore, no significant market share or revenue figures are currently reported.

  • Recent Developments, Partnerships, or Innovations: They have progressed through various stages of clinical trials for their bionic eye systems and received significant government and private funding in Australia.

  • Competitive Positioning and Strategic Focus: BVT’s strategic focus is on developing higher-resolution bionic eyes that can provide more functional vision for a broader range of activities. They are exploring both subretinal and supra-choroidal approaches.

  • Key Customers or Industries Served: Currently, clinical trial participants with severe vision loss due to retinal degeneration.

5. Nano Retina, Inc.

  • Company Name and Headquarters: Nano Retina, Inc. (Herzliya, Israel)

  • Product Offerings related to Smart Retinal Implants:

    • NR600 Implant: A miniature, wireless subretinal implant designed to restore sight to patients with degenerative retinal diseases like AMD and retinitis pigmentosa. It’s powered by an external eyeglass-mounted device and doesn’t require complex external cameras or processing units.

  • Market Share and Estimated Revenue from Smart Retinal Implants Segment: Nano Retina is in the earlier stages of clinical development, so no substantial market share or revenue is currently generated from product sales.

  • Recent Developments, Partnerships, or Innovations: They are advancing their NR600 system through pre-clinical and early clinical studies. Their focus is on miniaturization and simplifying the overall system for improved patient experience.

  • Competitive Positioning and Strategic Focus: Nano Retina aims to differentiate itself through the small size, wireless nature, and relatively straightforward implantation procedure of its device, making it potentially accessible to a wider patient population.

  • Key Customers or Industries Served: Future patients with advanced retinal degenerations, and ophthalmologists.

6. Intelligent Implants GmbH

  • Company Name and Headquarters: Intelligent Implants GmbH (Hamburg, Germany)

  • Product Offerings related to Smart Retinal Implants: While their primary focus has historically been on “intelligent” orthopedic implants that monitor and stimulate bone healing, their core technology in smart, wirelessly powered, and data-transmitting implants has potential crossover applications. They don’t currently have a dedicated retinal implant product on the market.

  • Market Share and Estimated Revenue from Smart Retinal Implants Segment: Not applicable, as they don’t have a direct retinal implant product.

  • Recent Developments, Partnerships, or Innovations: Their innovations are in smart medical devices with integrated sensors and wireless communication. This expertise could, in theory, be applied to future generations of retinal implants requiring complex data transfer or monitoring.

  • Competitive Positioning and Strategic Focus: Their strategic focus is on intelligent, connected implantable medical devices. If they enter the retinal implant space, it would likely be with highly advanced, data-rich devices.

  • Key Customers or Industries Served: Primarily orthopedics and other areas requiring smart implants for monitoring and therapy.

7. iBionics

  • Company Name and Headquarters: iBionics (Montreal, Canada)

  • Product Offerings related to Smart Retinal Implants:

    • Diamond Eye System: This is a high-resolution subretinal implant designed to restore useful vision. It leverages diamond-based electrode arrays for biocompatibility and efficient stimulation.

  • Market Share and Estimated Revenue from Smart Retinal Implants Segment: iBionics is in the pre-clinical and early clinical development phase. No significant market share or revenue from product sales yet.

  • Recent Developments, Partnerships, or Innovations: They are working on developing their Diamond Eye technology and advancing it through regulatory pathways.

  • Competitive Positioning and Strategic Focus: iBionics aims to achieve high-resolution visual restoration through its innovative diamond-based technology, which offers unique electrical and biocompatibility properties.

  • Key Customers or Industries Served: Future patients with retinal degenerations.

8. Optobionics Corporation

  • Company Name and Headquarters: Optobionics Corporation (Chicago, Illinois, USA – now largely defunct/absorbed)

  • Product Offerings related to Smart Retinal Implants:

    • Artificial Silicon Retina (ASR) microchip: This was a subretinal photovoltaic chip designed to restore vision in patients with retinitis pigmentosa and macular degeneration. It was a pioneering effort in subretinal implants.

  • Market Share and Estimated Revenue from Smart Retinal Implants Segment: Optobionics was an early innovator but ultimately did not achieve widespread commercial success. Their technology and research contributed to the field but are not currently a market player.

  • Recent Developments, Partnerships, or Innovations: The company’s work largely concluded, but its research significantly influenced subsequent subretinal implant development.

  • Competitive Positioning and Strategic Focus: Historically, their focus was on the self-powered subretinal chip.

  • Key Customers or Industries Served: Primarily clinical trial participants in the past.

9. VisionCare Ophthalmic Technologies

  • Company Name and Headquarters: VisionCare Ophthalmic Technologies (Saratoga, California, USA)

  • Product Offerings related to Smart Retinal Implants:

    • Implantable Miniature Telescope (IMT): While not a “smart retinal implant” in the same sense as electronic prostheses, the IMT is an important implantable device for end-stage Age-related Macular Degeneration (AMD). It magnifies images, projecting them onto healthier areas of the retina.

  • Market Share and Estimated Revenue from Smart Retinal Implants Segment: Not directly applicable to “smart retinal implants” as defined by electronic prostheses. However, the IMT has a niche market for severe AMD.

  • Recent Developments, Partnerships, or Innovations: They continue to offer the IMT and improve patient selection and rehabilitation protocols.

  • Competitive Positioning and Strategic Focus: VisionCare focuses on optical magnification for advanced AMD, offering an alternative to electronic prostheses for certain patient groups.

  • Key Customers or Industries Served: Patients with end-stage, bilateral Age-related Macular Degeneration who meet specific criteria.

10. Ocumetics Technology Corporation

  • Company Name and Headquarters: Ocumetics Technology Corporation (Abbotsford, British Columbia, Canada)

  • Product Offerings related to Smart Retinal Implants: Their primary product in development is the Bionic Lens, which is designed to replace the natural lens of the eye to provide “better than 20/20” vision, addressing presbyopia, cataracts, and other refractive errors. This is more of an advanced intraocular lens (IOL) than a retinal implant in the context of restoring vision from retinal degeneration. It’s a “smart” lens, but not a “smart retinal implant.”

  • Market Share and Estimated Revenue from Smart Retinal Implants Segment: Not applicable, as their Bionic Lens is not a retinal implant for retinal degeneration.

  • Recent Developments, Partnerships, or Innovations: They are in advanced stages of clinical development for their Bionic Lens.

  • Competitive Positioning and Strategic Focus: Ocumetics’ strategic focus is on revolutionizing vision correction and enhancement through their advanced intraocular lens technology.

  • Key Customers or Industries Served: Future patients seeking permanent vision correction and enhancement, particularly those with presbyopia, cataracts, or other refractive errors.

11. Nidek Co., Ltd.

  • Company Name and Headquarters: Nidek Co., Ltd. (Gamagori, Japan)

  • Product Offerings related to Smart Retinal Implants: Nidek is a global leader in ophthalmic and optometric equipment, producing a wide range of diagnostic, surgical, and therapeutic devices (e.g., refractors, slit lamps, fundus cameras, excimer lasers). They do not directly produce smart retinal implants.

  • Market Share and Estimated Revenue from Smart Retinal Implants Segment: Not applicable.

  • Recent Developments, Partnerships, or Innovations: Nidek continuously innovates in ophthalmic imaging, diagnostics, and laser surgery, which are complementary to retinal implant procedures but not direct products.

  • Competitive Positioning and Strategic Focus: Nidek’s strategic focus is on being a comprehensive provider of high-quality ophthalmic equipment to eye care professionals worldwide.

  • Key Customers or Industries Served: Ophthalmologists, optometrists, eye clinics, and hospitals globally.

12. Boston Scientific Corporation

  • Company Name and Headquarters: Boston Scientific Corporation (Marlborough, Massachusetts, USA)

  • Product Offerings related to Smart Retinal Implants: Boston Scientific is a global medical technology leader, primarily in cardiovascular, neurological, urological, and gastrointestinal devices. They do not currently have products directly in the smart retinal implants market. However, their expertise in neurostimulation (e.g., spinal cord stimulators, deep brain stimulators) offers a strong technological foundation if they were to enter the visual prosthetics space.

  • Market Share and Estimated Revenue from Smart Retinal Implants Segment: Not applicable.

  • Recent Developments, Partnerships, or Innovations: They are active in various neurostimulation fields. While not directly retinal, their technology in neuromodulation is highly relevant.

  • Competitive Positioning and Strategic Focus: Boston Scientific’s strategic focus is on developing innovative medical solutions across a broad range of therapeutic areas. Their potential entry into retinal implants would leverage their neurostimulation expertise.

  • Key Customers or Industries Served: Hospitals, clinics, and healthcare providers across numerous medical specialties.

13. Medtronic plc

  • Company Name and Headquarters: Medtronic plc (Dublin, Ireland – global operations)

  • Product Offerings related to Smart Retinal Implants: Medtronic is the world’s largest medical technology company, with extensive portfolios in cardiac, surgical, diabetes, and neurological devices. Similar to Boston Scientific, they do not have dedicated smart retinal implant products. However, their deep expertise in neurostimulation (e.g., for Parkinson’s, epilepsy, chronic pain) and implantable medical devices positions them as a potential future player or partner.

  • Market Share and Estimated Revenue from Smart Retinal Implants Segment: Not applicable.

  • Recent Developments, Partnerships, or Innovations: Medtronic is at the forefront of neurostimulation research and development. Their work in brain-computer interfaces and advanced implantable systems is highly relevant to visual prosthetics.

  • Competitive Positioning and Strategic Focus: Medtronic’s strategic focus is on transforming healthcare with advanced medical technologies. Their extensive R&D and global reach make them a formidable potential entrant or collaborator in high-tech medical fields like retinal implants.

  • Key Customers or Industries Served: Hospitals, healthcare systems, and patients worldwide across virtually all major medical specialties.

14. Alcon (Novartis)

  • Company Name and Headquarters: Alcon (Geneva, Switzerland – formerly a division of Novartis, now an independent company)

  • Product Offerings related to Smart Retinal Implants: Alcon is a global leader in eye care products, including surgical equipment, intraocular lenses (IOLs), and contact lenses. They do not currently produce smart retinal implants. Their focus is on traditional ophthalmic solutions, including cataract surgery, vitreoretinal surgery equipment, and glaucoma devices.

  • Market Share and Estimated Revenue from Smart Retinal Implants Segment: Not applicable.

  • Recent Developments, Partnerships, or Innovations: Alcon continuously innovates in surgical ophthalmology, IOL technology, and contact lens materials.

  • Competitive Positioning and Strategic Focus: Alcon’s strategic focus is on being the premier eye care company, providing comprehensive products for surgical and vision care.

  • Key Customers or Industries Served: Ophthalmologists, optometrists, eye surgeons, and patients globally.

15. Johnson & Johnson Vision Care, Inc.

  • Company Name and Headquarters: Johnson & Johnson Vision Care, Inc. (Jacksonville, Florida, USA – part of Johnson & Johnson)

  • Product Offerings related to Smart Retinal Implants: J&J Vision is a major player in eye health, primarily known for contact lenses (Acuvue), surgical products (cataract, laser refractive surgery), and consumer eye health. They do not currently produce smart retinal implants.

  • Market Share and Estimated Revenue from Smart Retinal Implants Segment: Not applicable.

  • Recent Developments, Partnerships, or Innovations: J&J Vision invests heavily in R&D for contact lens technology, surgical instruments, and digital solutions in eye care.

  • Competitive Positioning and Strategic Focus: J&J Vision’s strategic focus is on addressing uncorrected refractive error, cataracts, and other eye conditions through a broad portfolio of products.

  • Key Customers or Industries Served: Ophthalmologists, optometrists, optical retailers, and consumers globally.

16. Zeiss Group

  • Company Name and Headquarters: Zeiss Group (Oberkochen, Germany)

  • Product Offerings related to Smart Retinal Implants: Zeiss is a global technology leader in optics and optoelectronics, producing a vast array of products from microscopes and industrial measurement tools to camera lenses and planetarium technology. In ophthalmology, they are a leading provider of diagnostic equipment (e.g., OCT, fundus cameras), surgical microscopes, and femtosecond lasers for refractive surgery. They do not directly produce smart retinal implants.

  • Market Share and Estimated Revenue from Smart Retinal Implants Segment: Not applicable.

  • Recent Developments, Partnerships, or Innovations: Zeiss is continuously at the forefront of optical and imaging technology, with significant innovations in medical imaging and surgical visualization crucial for retinal procedures.

  • Competitive Positioning and Strategic Focus: Zeiss’s strategic focus is on advancing technology in optics and optoelectronics across multiple sectors, including a strong presence in high-end ophthalmic diagnostics and surgery.

  • Key Customers or Industries Served: Researchers, industrial manufacturers, healthcare providers (especially ophthalmologists and optometrists), and scientific institutions worldwide.

17. Ophthorobotics AG

  • Company Name and Headquarters: Ophthorobotics AG (Zurich, Switzerland)

  • Product Offerings related to Smart Retinal Implants: Ophthorobotics focuses on developing robotic systems for ophthalmic injections, specifically for conditions like Wet AMD and Diabetic Macular Edema. While their technology is advanced and aims to automate and improve retinal treatments, they are not developing “smart retinal implants” that electrically stimulate the retina.

  • Market Share and Estimated Revenue from Smart Retinal Implants Segment: Not applicable.

  • Recent Developments, Partnerships, or Innovations: They are pioneering robotic systems for precise and consistent intravitreal injections, which could transform the delivery of therapies for retinal diseases.

  • Competitive Positioning and Strategic Focus: Their strategic focus is on bringing robotics to ophthalmic procedures to enhance safety, precision, and efficiency for patients and clinicians.

  • Key Customers or Industries Served: Ophthalmologists and eye clinics that perform a high volume of intravitreal injections.

18. Gensight Biologics

  • Company Name and Headquarters: GenSight Biologics (Paris, France)

  • Product Offerings related to Smart Retinal Implants: GenSight Biologics is a clinical-stage biotechnology company focused on developing gene therapies for retinal degenerative diseases and central nervous system disorders. Their lead product candidate, LUMEVOQ®, is for Leber Hereditary Optic Neuropathy (LHON). Their optogenetic gene therapy approach (e.g., GS030) involves introducing genes that make retinal cells light-sensitive, thereby functionally acting like an “implant” but through biological means rather than electronic hardware.

  • Market Share and Estimated Revenue from Smart Retinal Implants Segment: Not directly applicable to “electronic smart retinal implants.” However, their optogenetic therapies represent a competing and potentially complementary approach to restoring vision in retinal degeneration.

  • Recent Developments, Partnerships, or Innovations: GenSight is a leader in optogenetic gene therapy for retinal diseases, with promising clinical trial results.

  • Competitive Positioning and Strategic Focus: GenSight’s strategic focus is on developing groundbreaking gene therapies that leverage the body’s own cells to restore vision, offering a different paradigm from electronic prostheses.

  • Key Customers or Industries Served: Patients with specific genetic retinal diseases, particularly LHON and retinitis pigmentosa, and collaborating with ophthalmologists and gene therapy centers.

19. LambdaVision, Inc.

  • Company Name and Headquarters: LambdaVision, Inc. (Farmington, Connecticut, USA)

  • Product Offerings related to Smart Retinal Implants: LambdaVision is developing a protein-based artificial retina. This implant utilizes bacteriorhodopsin, a light-activated protein, to create a thin, stable, and highly sensitive photodetector layer that could potentially replace damaged photoreceptors.

  • Market Share and Estimated Revenue from Smart Retinal Implants Segment: LambdaVision is in the research and development phase, with ongoing pre-clinical and early clinical work, including experiments on the International Space Station for manufacturing. No significant market share or revenue yet.

  • Recent Developments, Partnerships, or Innovations: Their innovative approach to a protein-based implant offers potential advantages in biocompatibility and integration. They’re also exploring space-based manufacturing for optimal film quality.

  • Competitive Positioning and Strategic Focus: LambdaVision aims to offer a novel, biocompatible, and high-resolution artificial retina using a unique protein-based technology.

  • Key Customers or Industries Served: Future patients with various forms of retinal degeneration.

20. Neurotech Pharmaceuticals, Inc.

  • Company Name and Headquarters: Neurotech Pharmaceuticals, Inc. (Lincoln, Rhode Island, USA)

  • Product Offerings related to Smart Retinal Implants: Neurotech focuses on developing encapsulated cell technology (ECT) for chronic retinal diseases. This involves surgically implanting a small, permeable device that delivers therapeutic proteins (e.g., ciliary neurotrophic factor, CNTF) directly to the retina. While an “implant,” it’s a drug delivery device rather than an electronic smart retinal implant that electrically stimulates vision.

  • Market Share and Estimated Revenue from Smart Retinal Implants Segment: Not applicable to “electronic smart retinal implants.” Their revenue would be in the therapeutic implant space.

  • Recent Developments, Partnerships, or Innovations: They have conducted multiple clinical trials for their ECT platform in conditions like retinitis pigmentosa and macular telangiectasia.

  • Competitive Positioning and Strategic Focus: Neurotech’s strategic focus is on long-term, continuous delivery of neurotrophic factors directly to the retina to slow or halt degeneration, rather than restoring lost vision through electrical stimulation.

  • Key Customers or Industries Served: Patients with chronic retinal diseases, and ophthalmologists specializing in retinal care.

Contact Us

Related Posts

Scroll to Top